Page last updated: 2024-08-24

arctigenin and Alloxan Diabetes

arctigenin has been researched along with Alloxan Diabetes in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Ahmed, AAM; El-Sayed, NM; Medras, ZJH; Mostafa, YM1
Azeloglu, EU; Chen, Y; Das, B; Deng, Y; He, JC; Lee, K; Li, X; Liu, R; Ma, Y; Muwonge, AN; Wang, T; Wei, C; Wong, NJ; Yang, S; Zhang, W; Zhong, Y1
Cao, P; Gui, J; Han, J; Wang, G; Wang, X; Wang, Y; Zhang, J1
Feng, Y; Gu, C; Ju, J; Ruan, K; Wang, H; Wang, K; Xu, Z1
Dai, Y; Dong, S; He, NN; Jiang, CJ; Xia, YF; Zeng, XY1

Other Studies

5 other study(ies) available for arctigenin and Alloxan Diabetes

ArticleYear
Arctigenin improves neuropathy via ameliorating apoptosis and modulating autophagy in streptozotocin-induced diabetic mice.
    CNS neuroscience & therapeutics, 2023, Volume: 29, Issue:10

    Topics: Animals; Antioxidants; Apoptosis; Autophagy; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Lignans; Mice; Oxidative Stress; Streptozocin

2023
Arctigenin attenuates diabetic kidney disease through the activation of PP2A in podocytes.
    Nature communications, 2019, 10-04, Volume: 10, Issue:1

    Topics: Animals; Arctium; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Furans; Humans; Lignans; Male; Mice; Mice, Knockout; Microscopy, Electron, Transmission; Nitric Oxide Synthase Type III; Podocytes; Protein Phosphatase 2; Streptozocin; Treatment Outcome

2019
Arctigenin ameliorates renal impairment and inhibits endoplasmic reticulum stress in diabetic db/db mice.
    Life sciences, 2019, Apr-15, Volume: 223

    Topics: Animals; Apoptosis; Arctium; Cell Culture Techniques; Cell Line; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Endoplasmic Reticulum Stress; Epithelial Cells; Furans; Humans; Hypoglycemic Agents; Kidney; Lignans; Male; Mice, Inbred C57BL

2019
Arctigenic acid, the key substance responsible for the hypoglycemic activity of Fructus Arctii.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2015, Jan-15, Volume: 22, Issue:1

    Topics: Animals; Arctium; Chromatography, High Pressure Liquid; Diabetes Mellitus, Experimental; Female; Fruit; Furans; Glucose; Glucose Tolerance Test; Glycated Hemoglobin; Hypoglycemic Agents; Lignans; Male; Mice, Inbred ICR; Molecular Structure; Rats; Rats, Wistar; Tandem Mass Spectrometry; Toxicity Tests, Acute

2015
Comparative pharmacokinetics of arctigenin in normal and type 2 diabetic rats after oral and intravenous administration.
    Fitoterapia, 2015, Volume: 105

    Topics: Administration, Intravenous; Administration, Oral; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Diabetes Mellitus, Experimental; Furans; Intestinal Absorption; Lignans; Male; Molecular Structure; Rats; Rats, Sprague-Dawley

2015